| | | | |
CUSIP NO. 29286M105 | | 13G | | Page 8 of 10 Pages |
Introductory Note: This statement on Schedule 13G is filed on behalf of the Reporting Persons, in respect of Common Shares, no par value per share (the “Common Shares”), of enGene Holdings, Inc. (the “Issuer”).
enGene Holdings, Inc. (the “Issuer”)
Item 1(b) | Address of Issuer’s principal executive offices: |
enGene Holdings, Inc.
4868 Rue Levy, Suite 220
Saint-Laurent, QC, Canada
Items 2(a) | Name of Reporting Persons filing: |
Omega Fund VII, L.P. (“Omega Fund”)
Omega Fund VII GP, L.P. (“Omega GP”)
Omega Fund VII GP Manager, Ltd. (“Omega Ltd”)
Claudio Nessi (“Nessi”)
Otello Stampacchia (“Stampacchia”)
Francesco Draetta (“Draetta”)
Item 2(b) | Address or principal business office or, if none, residence: |
The address of the principal business office of Omega Fund, Omega GP, Omega Ltd, Nessi, Stampacchia and Draetta, is c/o Omega Fund Management, LLC, 888 Boylston Street, Suite 1111, Boston, MA 02199.
| | |
Name | | Citizenship or Place of Organization |
Omega Fund | | Cayman Islands |
Omega GP | | Cayman Islands |
Omega Ltd | | Cayman Islands |
Nessi | | Switzerland |
Stampacchia | | Italy |
Draetta | | United States |
Item 2(d) | Title of class of securities: |
Common Shares
29286M105
Item 3 | If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filings is a: |
Not applicable.